ArticleClinical pharmacology and therapeutics2021

Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity.

Yiwei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.